| Oct 23 |
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
| Oct 23 |
The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen
|
| Oct 22 |
Incyte Gears Up to Report Q3 Earnings: Here's What You Should Know
|
| Oct 22 |
5 Large Drug Stocks Likely to Outpace Q3 Earnings Estimates
|
| Oct 21 |
Novartis Gets CHMP Recommendation for Kisqali in Broader Population
|
| Oct 18 |
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
|
| Oct 18 |
Novartis receives positive CHMP opinion for its breast cancer treatment
|
| Oct 18 |
PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug
|
| Oct 18 |
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
|
| Oct 17 |
Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
|
